Biohaven Q2 Adj. EPS $(0.78) Misses $(0.73) Estimate
Biohaven (NYSE:BHVN) reported quarterly losses of $(0.78) per share which missed the analyst consensus estimate of $(0.73) by 6.85 percent. This is a 52.15 percent increase over losses of $(1.63) per share from the same
Biohaven lost more money per share than experts predicted, though it's losing less overall than it did last year. When a company misses what people expected, it can make investors nervous, even if the direction is getting better.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.